An Inflammatory Checkpoint Generated by <i>IL1RN</i> Splicing Offers Therapeutic Opportunity for <i>KRAS</i> -Mutant Intrahepatic CholangiocarcinomaMao Zhang, Qiang Gao, Yingying Huang et al.|Cancer Discovery|2023Cited by 42
Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroupsShunrong Ji, Xianjun Yu, Lihua Cao et al.|Cancer Cell|2025Cited by 25
Supplementary Figures S1-9 from An Inflammatory Checkpoint Generated by <i>IL1RN</i> Splicing Offers Therapeutic Opportunity for <i>KRAS</i>-Mutant Intrahepatic CholangiocarcinomaMao Zhang, Qiang Gao, Yingying Huang et al.|Unknown|2023Cited by 0
Supplementary Table S3 from An Inflammatory Checkpoint Generated by <i>IL1RN</i> Splicing Offers Therapeutic Opportunity for <i>KRAS</i>-Mutant Intrahepatic CholangiocarcinomaMao Zhang, Qiang Gao, Yingying Huang et al.|Unknown|2023Cited by 0
Supplementary Table S1 from An Inflammatory Checkpoint Generated by <i>IL1RN</i> Splicing Offers Therapeutic Opportunity for <i>KRAS</i>-Mutant Intrahepatic CholangiocarcinomaMao Zhang, Qiang Gao, Yingying Huang et al.|Unknown|2023Cited by 0